HCV viraemia is more important than genotype as a predictor of response to interferon in sicily (Southern Italy)

Tinè, 1991, Interferon in nonA nonB hepatitis: a meta-analysis of randomised clinical trials, J Hepatol, 13, 192, 10.1016/0168-8278(91)90814-R Serfaty, 1994, Factors predictive of the response to interferon in patients with chronic hepatitis C, J Hepatol, 21, 12, 10.1016/S0168-8278(94)80130-4 Pagliaro, 1994, Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response, Hepatology, 19, 820 Yoshioka, 1992, Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus, Hepatology, 16, 293, 10.1002/hep.1840160203 Kobayashi, 1993, Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon beta, Hepatology, 18, 1319, 10.1002/hep.1840180606 Aiyama, 1994, Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C, Dig Dis Sci, 39, 2244, 10.1007/BF02090379 Tsubota, 1994, Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection, Hepatology, 19, 1088, 10.1002/hep.1840190505 Mita, 1994, Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer, Dig Dis Sci, 39, 977, 10.1007/BF02087547 Matsumoto, 1994, Viral and host factors that contribute to efficacy of interferon-alpha2a therapy in patients with chronic hepatitis C, Dig Dis Sci, 39, 1273, 10.1007/BF02093793 Hayashi, 1994, A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C, Am J Gastroenterol, 89, 2151 Yun, 1994, Serum hepatitis C virus RNA levels in chronic hepatitis C. Importance for outcome of interferon-alpha2b treatment, Scand J Infect Dis, 26, 263, 10.3109/00365549409011794 Lau, 1993, Significance of serum hepatitis C virus RNA levels in chronic hepatitis C, Lancet, 341, 1501, 10.1016/0140-6736(93)90635-T Magrin, 1994, Hepatitis C viraemia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment, Hepatology, 19, 273, 10.1002/hep.1840190203 Orito, 1994, Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C, J Med Virol, 44, 410, 10.1002/jmv.1890440418 Mahaney, 1994, Genotypic analysis of hepatitis C virus in American patients, Hepatology, 20, 1405, 10.1002/hep.1840200605 Rumi, 1994, Randomized comparative study of recombinant alpha and lymphoblastoid interferon in patients with chronic active hepatitis C, J Hepatol, 21, S27, 10.1016/S0168-8278(05)80764-0 Ravaggi, 1994, HCV genotype and viraemia: predictive value for early and sustained response to interferon therapy, J Hepatol, 21, S64, 10.1016/S0168-8278(05)80904-3 Portal, 1994, Predictive value of serum HCV-RNA levels and genotypes for response to interferon alpha therapy, Hepatology, 20, 156A Mizokami, 1994, Predictors of long-term response to interferon-alpha therapy in Japanese patients with chronic hepatitis C, Hepatology, 20, 158A Nousbaum, 1995, Hepatitis C virus type 1b (II) infection in France and Italy, Ann Intern Med, 122, 161, 10.7326/0003-4819-122-3-199502010-00001 Yamada, 1995, Efficacy of interferon alfa therapy in chronic hepatitis C dependents primarily on hepatitis C virus RNA level, Hepatology, 22, 1351 Martinot-Peignoux, 1995, Pretreatment serum HCV-RNA levels and HCV genotype are the main independent prognostic factors of sustained response to alpha interferon therapy in chronic hepatitis C, Hepatology, 22, 1050, 10.1002/hep.1840220406 Dusheiko, 1994, Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease, Hepatology, 19, 13, 10.1002/hep.1840190104 Pol, 1995, The changing prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients, Gastroenterology, 108, 581, 10.1016/0016-5085(95)90088-8 Pawlotsky, 1995, Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C, J Infect Dis, 171, 1607, 10.1093/infdis/171.6.1607 Pontisso, 1995, Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 495 patients with chronic hepatitis C, J Viral Hepatitis, 2, 33, 10.1111/j.1365-2893.1995.tb00069.x Knodell, 1981, Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis, Hepatology, 1, 431, 10.1002/hep.1840010511 Di Bisceglie, 1991, Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis, Hepatology, 14, 969, 10.1002/hep.1840140603 Desmet, 1994, Classification of chronic hepatitis: diagnosis, grading and staging, Hepatology, 19, 1513, 10.1002/hep.1840190629 Urdea, 1991, Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses, Nucl Acids Res, 24, 197 Okamoto, 1990, The 5′-terminal sequence of hepatitis C virus genome, Jpn J Exp Med, 60, 167 Kwok, 1989, Avoiding false positives with PCR, Nature, 339, 237, 10.1038/339237a0 Kowk, 1989, Nature, 339, 490 Lau, 1995, Implications of variations of “conserved” regions of hepatitis C virus genome, Lancet, 345, 425, 10.1016/S0140-6736(95)92786-7 Stuyver, 1993, Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay, J Gen Virol, 74, 1093, 10.1099/0022-1317-74-6-1093 Casanova, 1990, Optimal conditions for directly sequencing double-stranded PCR products with Sequenase, Nucl Acids Res, 18, 4028, 10.1093/nar/18.13.4028 Sanger, 1977, DNA sequencing with chain-terminating inhibitors, Proc Natl Acad Sci USA, 74, 5463, 10.1073/pnas.74.12.5463 Tabor, 1987, DNA sequence analysis with a modified bacteriophage T7 DNA polymerase, Proc Natl Acad Sci USA, 4767, 10.1073/pnas.84.14.4767 Newton, 1988, Diagnosis of alpha-1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequenching of polymerase chain reaction products, Nucl Acids Res, 16, 8234, 10.1093/nar/16.17.8233 1990, 1 Van Doorn, 1994, Review: molecular biology of the hepatitis C virus, J Med Virol, 43, 345, 10.1002/jmv.1890430406 Smith, 1995, Variation of the hepatitis C virus 5′ non-coding region: implications for secondary structure, virus detection and typing, J Gen Virol, 76, 1749, 10.1099/0022-1317-76-7-1749 Wasson, 1985, Clinical prediction rules. Applications and methodological standards, N Engl J Med, 313, 793, 10.1056/NEJM198509263131306 Harrel, 1985, Regression Models for prognostic prediction: advantages, problems, and suggested solutions, Cancer Treat Rep, 69, 1071 Chemello, 1994, Hepatitis C serotype and response to interferon therapy, N Engl J Med, 330, 143, 10.1056/NEJM199401133300215 Dusheiko, 1994, The influence of serotypes of hepatitis C virus on sustained response to alpha interferon treatment, J Hepatol, 21, S17, 10.1016/S0168-8278(05)80730-5 Van Doorn, 1994, Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles, J Hepatol, 21, 122, 10.1016/S0168-8278(94)80148-7 Lau, 1995, Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States, J Infect Dis, 171, 281, 10.1093/infdis/171.2.281 Kasahara, 1995, Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial, Hepatology, 21, 291, 10.1002/hep.1840210205 Chemello, 1995, Hepatology, 22, 700 Kanazawa, 1994, Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients, Hepatology, 20, 1121, 10.1002/hep.1840200504 Moribe, 1995, Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy, Gastroenterology, 108, 789, 10.1016/0016-5085(95)90452-2 Martell, 1992, Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution, J Virol, 66, 3225, 10.1128/JVI.66.5.3225-3229.1992 Tsukiyama-Kohara, 1992, Internal ribosome entry site within hepatitis C virus RNA, J Virol, 66, 1476, 10.1128/JVI.66.3.1476-1483.1992 Pozzato, 1994, Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease, J Med Virol, 43, 291, 10.1002/jmv.1890430318 Yamada, 1994, Hepatitis C virus genotypes are not responsible for development of serious liver disease, Dig Dis Sci, 39, 234, 10.1007/BF02090191